Medical application
Title
Date Published
Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients.
November 1, 2013
Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update [Internet].
April 1, 2013
Update on erythropoiesis-stimulating agents.
March 1, 2013
Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins.
February 11, 2013
Erythropoietin levels in patients with multiple sclerosis complicated with anemia. [Article in Chinese]
February 1, 2013
Regulation of erythropoiesis by hypoxia-inducible factors.
January 3, 2013
The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice.
December 12, 2012
Erythropoietin or darbepoetin for patients with cancer.
December 12, 2012
Shortened red blood cell lifespan is related to the dose of erythropoiesis-stimulating agents requirement in patients on hemodialysis.
December 1, 2012
Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients.
November 20, 2012
Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia.
October 30, 2012
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.
August 22, 2012
Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea.
June 23, 2012
Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
December 16, 2011
Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes.
November 18, 2011
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery.
November 1, 2011
A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia.
October 11, 2010
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients.
October 6, 2010
Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study.
July 31, 2010
Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone.
July 23, 2010